Business Context and Reporting Period
This Form 8-K Current Report was filed by Viemed Healthcare, Inc. on May 19, 2020, covering an event that occurred on May 5, 2020. The Company is incorporated in British Columbia, Canada, and its common shares trade on The Nasdaq Stock Market LLC under the symbol "VMD".
Key Financial Metrics
The filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity figures. The document focuses exclusively on corporate governance and executive compensation matters.
Material Changes
On May 5, 2020, the Board of Directors established performance criteria for the Viemed Inc. Annual Discretionary Cash Bonus Plan. The criteria are weighted as follows:
- 70% Financial and Operational Goals: Includes Adjusted EBITDA, revenue, business line growth, and number of patients.
- 30% Corporate Goals: Includes capital deployment opportunities, technological capabilities, internal leadership and communications, corporate governance, and staffing levels.
The Compensation Committee retains sole discretion to determine the actual bonus amounts awarded.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on market outlook, specific risk factors, or contingencies beyond the establishment of the bonus plan. The plan participants include named executive officers Casey Hoyt, Michael Moore, W. Todd Zehnder, Trae Fitzgerald, and Jerome Cambre.
Investor Verification Checklist
- Verify the specific Adjusted EBITDA targets and revenue thresholds set for the 2020 fiscal year in subsequent filings or proxy statements.
- Confirm the total potential payout pool for the Annual Discretionary Cash Bonus Plan.
- Review the Company's most recent 10-K or 10-Q for actual financial performance against the newly established criteria.
- Monitor future 8-K filings for any changes to executive compensation or the departure of the named officers.